Predischarge Bundle to Minimize Negative Impact on Quality of Life of Nuisance Bleedings

NACompletedINTERVENTIONAL
Enrollment

448

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2017

Conditions
Myocardial IschemiaHemorrhageQuality of LifePlatelet Aggregation Inhibitors
Interventions
BEHAVIORAL

good clinical practice

education from physician regarding dual antiplatelet therapy as part of the routine discharge process

BEHAVIORAL

bundle group

visits and materials describing advantages and side effects of dual antiplatelet therapy and their management

Trial Locations (1)

44124

University Hospital of Ferrara, Cona

All Listed Sponsors
lead

University Hospital of Ferrara

OTHER

NCT02554006 - Predischarge Bundle to Minimize Negative Impact on Quality of Life of Nuisance Bleedings | Biotech Hunter | Biotech Hunter